Five Year Study to Track Use of DecisionDX-Melanoma Test in Patients With Cutaneous Melanoma and Associated Patient Outcomes

计划入组 72 人 · 首次发布于 2015 年 2 月 4 日

5-year Study to Track Clinical Application of DecisionDx-Melanoma Gene Expression Profile Assay Results

计划入组 301 人 · 首次发布于 2015 年 2 月 4 日

Safety Study of a Melanoma Vaccine (GVAX) With or Without Cyclophosphamide in Patients With Surgically Resected Melanoma

计划入组 21 人 · 首次发布于 2011 年 9 月 16 日

melanoma vaccine

Melanoma(FAKnostics)

Melanoma(OncoTartis)

MELANOMA INSTITUTE AUSTRALIA

Australia

MELANOMA AND SKIN CANCER TRIALS LIMITED

Australia

DR. LYNN E. SPITLER, MD

United States

DecisionDx-Melanoma Test Reduces Unnecessary Biopsies in Melanoma Patients

Castle Biosciences' Gene Expression Tests Show Superior Survival Prediction in Melanoma Patients

GEP Tests Show Promise and Limitations in Melanoma Sentinel Lymph Node Biopsy Decisions